D

Danaher

Makes tools for drug research and medical testing

Open Innovation Director

Corporate StrategyConfirmed live in the last 24 hours
Full-timeShanghai, ChinaNo salary listedIn-person

About the Job

Requirements

  • A Master's degree or above in Chemical Engineering, Materials Science, Biotechnology, or related fields is required.
  • At least 5 years of experience in one or more of open innovation or external technology sourcing, technology transfer or partnerships, early-stage technology or platform incubation, or the bioprocess hardware and consumables ecosystem.
  • Deep understanding and experience building complex business cases.
  • Ability to operate in high-ambiguity, high-influence roles.
  • Strong understanding of the China biotech and bioprocess innovation ecosystem.
  • Good knowledge of automation, mechanistic modeling, and data-driven methods or machine learning.
  • Fluency in English and Chinese.

Responsibilities

  • Drive China Open Innovation activities aligned with future disruptive revenue opportunities, China strategy, and global technology vectors.
  • Identify external technologies, platforms, or partnership models that could provide Cytiva with step-change or non-linear advantage.
  • Monitor and analyze technology, ecosystem, and business model trends relevant to AI+ for bioprocess hardware and consumables.
  • Determine when and how Open Innovation pathways, versus internal development, should be applied in close alignment with China and Global stakeholders.
  • Proactively search, screen, and evaluate external technologies and partners in China earlier than competitors.
  • Build and maintain an external innovation ecosystem, including startups and scale-ups, academic and research institutions, bioparks and innovation hubs, and local and regional technology providers.
  • Lead partner assessments of technology maturity and differentiation, strategic fit with Cytiva capabilities, preliminary intellectual property landscape and risk with Legal/IP, and potential scalability and integration pathways.
  • Act as the primary Cytiva interface for external innovation partners during Open Innovation phases.
  • Design and evaluate collaboration and deal models, including license-in, joint development, and hybrid or staged partnership structures.
  • Lead or coordinate material transfer agreement and term sheet discussions, and alignment on collaboration scope, governance, and milestones.
  • Work with Legal, Finance, IP, Sourcing, and Business Units to ensure partnership structures are executable and risk-aware.
  • Drive Open Innovation initiatives through internal governance gates (TG0–TG2+).
  • Support portfolio-level prioritization across China Open Innovation, Global teams, operating companies, and Danaher China.
  • Ensure clear RACI, decision rights, and handoffs between Open Innovation, upstream product management, research and development, and Business Units.
  • Deploy and reinforce Danaher Business System Open Innovation tools and processes to enable transparency and leadership visibility.
  • Manage ongoing partner engagement through feasibility and early collaboration phases.
  • Ensure clear milestones and deliverables, risk identification and mitigation, and alignment across internal and external stakeholders.
  • Enable validated opportunities to transition smoothly into formal research and development programs, Product Management ownership, and manufacturing and supply chain systems.
  • Act as a technology and ecosystem bridge between China and Global teams.
  • Build relationships with key opinion leaders, academic leaders, and innovation communities.
  • Represent Cytiva in innovation forums, conferences, and bioparks.
  • Contribute to forward-looking strategic discussions on technology and external innovation.

Desired Qualifications

  • Hands-on experience with licensing, joint development, or strategic partnerships.
  • Familiarity with intellectual property risk management and global governance processes.
  • Ability to integrate technology insight with organizational execution.

About the Company

Danaher

Makes tools for drug research and medical testing

Danaher makes instruments, tests and laboratory supplies for drug developers, researchers and clinicians, spanning the path from biological research to clinical patient diagnosis. Its businesses include Cytiva for drug manufacturing, SCIEX for chemical analysis and Beckman Coulter for laboratory testing, linking specialized tools across healthcare workflows. Customers use its equipment to study cells, produce biological medicines and analyze patient samples; the group earns money by selling instruments, reagents, software and support services through its operating companies. Danaher was established in 1984 and is headquartered in Washington, DC.

Company size
10,001+
Company stage
IPO
Headquarters
Washington, DC
Founded
1984

Recently Posted Jobs

Explore more opportunities at Danaher

See more jobs